MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurobehavioral disorders"

  • 2016 International Congress

    Relationship of MDS-UPDRS non-motor symptoms to cognitive functioning in patients with Parkinson’s disease

    B.A. Bernard, D. Carns, G.T. Stebbins, J.G. Goldman, C.G. Goetz (Chicago, IL, USA)

    Objective: To evaluate the relationship among individual items from the MDS-UPDRS Part I and measures of cognitive functioning in patients with PD. Background: Non-motor symptoms…
  • 2016 International Congress

    Psychiatric manifestations in the initial motor stage of Parkinson’s disease

    I. Stankovic, E. Stefanova, A. Tomic, M. Jecmenica Lukic, V. Markovic, N. Kresojevic, I. Petrovic, M. Svetel, V.S. Kostic (Belgrade, Serbia)

    Objective: To estimate the prevalence and correlates of neuropsychiatric symptoms (NPS) in a cohort of consecutive patients with Parkinson's disease (PD) recruited in the initial…
  • 2016 International Congress

    A rapid chemical-genetic screen utilising impaired movement phenotypes in caenorhabditis elegans

    K. Schmeisser, Y.F. Ghassemi, C. Maios, A. Parker (Montreal, QC, Canada)

    Objective: Development of a fast and unbiased screening method to identify C. elegans mutants with movement disabilities and drugs to improve impaired locomotion. Background: Identifying…
  • 2016 International Congress

    The neurosteroid dehydroepiandrosterone sulfate (DHEAS) reverses the dopaminergic deficiencies in mild hepatic encephalopathy: A possible therapeutic issue for the management of parkinsonism in cirrhotic patients

    O. El Hiba, H. Gamrani (Marrakesh, Morocco)

    Objective: In the present study, we describe the changes of the dopaminergic system occurring in the cirrhotic rats and concomitantly we investigated the effect of…
  • 2016 International Congress

    Sensorimotor impairments and the excitability of spinal cord in lead intoxicated rat during development and a potent restorative effect of curcumin

    H. Benammi, O. El Hiba, H. Gamrani (Marrakesh, Morocco)

    Objective: In this study we firstly investigated the effect of prenatal exposure of rats to lead (3g/l) from neonatal to adult age, on the motor/sensory…
  • 2016 International Congress

    Amelioration of αLPHA-synuclein aggregation and motor behavior deficits by apocyanin in intranigral lipopolysaccharide induced animal model of Parkinson’s disease

    B. Nehru, N. Sharma (Chandigarh, India)

    Objective: The present study evaluated the therapeutic potentials of apocyanin for the treatment of neurobehavioral consequences in LPS induced PD model. Background: Parkinson's disease (PD),…
  • 2016 International Congress

    Influence of treadmill gait training with additional load on motor function, postural instability and history of falls for individuals with Parkinson’s disease: A randomized clinical trial

    L.C.L. Trigueiro, A.V.C. Sousa, G.L. Gama, T.S. Ribeiro, L.G.L.M. Ferreira, C.R. Simão, É.R.V.P. Galvão, E.M.G.S. Silva, C.G. Júnior, A.R.R. Lindquist (Natal, Brazil)

    Objective: The objective of this study was to evaluate the effects of additional load (5% and 10%) with treadmill gait training on the overall motor…
  • 2016 International Congress

    Voice harmonic amplitude differences before and after LSVT LOUDTM in Parkinson’s disease

    M.P. Cannito, L.O. Ramig, A.E. Halpern, J.L. Spielman (Lafayette, LA, USA)

    Objective: To evaluate voice harmonic amplitudes from acoustic spectra of speech produced by subjects with Parkinson's disease (PD) before and after voice treatment, in order…
  • 2016 International Congress

    Copper chelation efficacy of alginate/chitosan based D-penicillamine nanoparticles in rat model of non-Wilsonian brain copper toxicosis

    A. Pal, B.R. Thapa, R.K. Vasishta, R. Prasad (Chandigarh, India)

    Objective: To evaluate the copper (Cu) chelation efficacy of orally administered D-penicillamine loaded nanoparticles to that of conventional D-penicillamine therapy for 90 days in Wistar…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley